Wechsler ME, Colice G, Griffiths JM, Almqvist G, et al. SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled,
parallel group trial to evaluate the efficacy and safety of tezepelumab in
reducing oral corticosteroid use in adults with oral corticosteroid dependent
asthma. Respir Res 2020;21:264.
PMID: 33050928